Related Experiment Video
Updated: Aug 21, 2025
An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
Published on: November 30, 2022
Severe COVID-19 Pneumonia in an Unvaccinated Female Treated With Remdesivir
Kaylee Ortega1, Andrew George2, Charlotte R DeGeorge2
1Department of Biology, Trinity Preparatory School, Winter Park, USA.
Insights
This case study highlights successful remdesivir treatment for a severely obese, unvaccinated patient with COVID-19 pneumonia. It underscores the need to address vaccine hesitancy and obesity as critical public health concerns during the pandemic.
Area of Science:
- Infectious Diseases
- Public Health
- Critical Care Medicine
Background:
- The ongoing COVID-19 pandemic necessitates continuous evaluation of public health strategies and individual patient care.
- Obesity and vaccine hesitancy remain significant challenges impacting pandemic management and patient outcomes.
Observation:
- A case of a 34-year-old, unvaccinated, morbidly obese female presenting with severe COVID-19 pneumonia and respiratory distress.
- The patient received remdesivir therapy for management of the viral pneumonia.
Findings:
- Successful clinical recovery of the patient following remdesivir treatment.
- The case illustrates the complex interplay between obesity, vaccination status, and COVID-19 severity.
Implications:
- Reinforces the importance of addressing vaccine hesitancy to improve population immunity.
- Highlights obesity as a critical risk factor for severe COVID-19 outcomes, necessitating targeted public health interventions.
- Demonstrates the role of antiviral therapy in managing severe COVID-19 in high-risk individuals.
Abstract:
Though recent developments in the management of the coronavirus disease 2019 (COVID-19) pandemic have resulted in significant progress, its continued persistence demands continued consideration both of larger scale public health factors as well as individual patient management. We present a case that provides a broad perspective across several issues within both categories, of a morbidly obese 34-year-old unvaccinated female presenting with respiratory distress secondary to COVID-19 pneumonia, managed through remdesivir therapy. Though this case presents an example of successful management, it nonetheless emphasizes the demand for a renewed focus on vaccine hesitancy and obesity as public health issues, particularly within the context of the pandemic.
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
01:21Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:30Acute Respiratory Failure-III
01:29Pneumonia II: Pathophysiology
01:21Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...